Organization
Les Laboratoires Servier SAS
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Les Laboratoires Servier SAS

... Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan) and Servier jointly announced today the clinical data from the pivotal Phase III (TAGS) ...
... Paris - Servier, an independent international pharmaceutical company, today announced the launch of InnoPreP a ...
... $1.4 billion. The latest raise will go towards funding four trials of Servier-partnered lead candidate UCART19 in CD19-expressing blood cancers malignancies, as well as the ...
... in the arteries) caused by type 2 diabetes. Developed by French company Servier, Gliclazide (trade name: Diamicron) was first launched in France in 1972, and ...
... Paris and Pessac - Servier, an independent international pharmaceutical company, and Poietis, a leader in the production ...
... hit pause on its Allergan-partnered Alzheimer's program. GeNeuro lost its partnership with Servier. In better news, Argenx brought its primary immune thrombocytopenia drug through phase ...
... medicine industry in France. The project was jointly launched by Oncodesign (Paris:ALONC), Servier and Intersystems. With more than 45 innovative digital and medical companies already ...
... Servier has turned down the chance to license a multiple sclerosis drug from ...
... Regulatory News: Servier and GeNeuro (Paris:GNRO) (Euronext Paris: CH0308403085 - GNRO) announced today that GeNeuro ...
... milestones and royalties for each commercialized product. As for UCART19, Pfizer and Servier picked that up a year later. RELATED: Kite executives are back with ...
Subscribe now for full coverage on Les Laboratoires Servier SAS
Start My Free Trial